Ahn-Gook Pharmaceutical Statistics

Total Valuation

Ahn-Gook Pharmaceutical has a market cap or net worth of KRW 75.58 billion. The enterprise value is 120.18 billion.

Market Cap	75.58B
Enterprise Value	120.18B

Important Dates

The next estimated earnings date is Tuesday, February 25, 2025.

Earnings Date	Feb 25, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Ahn-Gook Pharmaceutical has 11.37 million shares outstanding. The number of shares has increased by 0.00% in one year.

Current Share Class	n/a
Shares Outstanding	11.37M
Shares Change (YoY)	+0.00%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	55.60%
Owned by Institutions (%)	0.23%
Float	5.05M

Valuation Ratios

The trailing PE ratio is 5.29.

PE Ratio	5.29
Forward PE	n/a
PS Ratio	0.29
PB Ratio	0.46
P/TBV Ratio	0.47
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.03, with an EV/FCF ratio of -1.73.

EV / Earnings	8.42
EV / Sales	0.45
EV / EBITDA	9.03
EV / EBIT	18.48
EV / FCF	-1.73

Financial Position

The company has a current ratio of 1.74, with a Debt / Equity ratio of 0.47.

Current Ratio	1.74
Quick Ratio	1.17
Debt / Equity	0.47
Debt / EBITDA	6.01
Debt / FCF	-1.12
Interest Coverage	2.77

Financial Efficiency

Return on equity (ROE) is 8.74% and return on invested capital (ROIC) is 1.83%.

Return on Equity (ROE)	8.74%
Return on Assets (ROA)	1.44%
Return on Capital (ROIC)	1.83%
Revenue Per Employee	661.59M
Profits Per Employee	35.70M
Employee Count	400
Asset Turnover	1.00
Inventory Turnover	2.68

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -18.90% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-18.90%
50-Day Moving Average	6,931.60
200-Day Moving Average	7,432.70
Relative Strength Index (RSI)	43.58
Average Volume (20 Days)	12,788

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ahn-Gook Pharmaceutical had revenue of KRW 264.64 billion and earned 14.28 billion in profits. Earnings per share was 1,256.56.

Revenue	264.64B
Gross Profit	159.44B
Operating Income	6.12B
Pretax Income	20.46B
Net Income	14.28B
EBITDA	12.92B
EBIT	6.12B
Earnings Per Share (EPS)	1,256.56

Full Income Statement

Balance Sheet

The company has 32.58 billion in cash and 77.63 billion in debt, giving a net cash position of -45.05 billion or -3,963.66 per share.

Cash & Cash Equivalents	32.58B
Total Debt	77.63B
Net Cash	-45.05B
Net Cash Per Share	-3,963.66
Equity (Book Value)	165.55B
Book Value Per Share	14,605.79
Working Capital	57.65B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.36 billion and capital expenditures -76.80 billion, giving a free cash flow of -69.45 billion.

Operating Cash Flow	7.36B
Capital Expenditures	-76.80B
Free Cash Flow	-69.45B
FCF Per Share	-6,110.23

Full Cash Flow Statement

Margins

Gross margin is 60.25%, with operating and profit margins of 2.31% and 5.40%.

Gross Margin	60.25%
Operating Margin	2.31%
Pretax Margin	7.73%
Profit Margin	5.40%
EBITDA Margin	4.88%
EBIT Margin	2.31%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 220.00, which amounts to a dividend yield of 3.31%.

Dividend Per Share	220.00
Dividend Yield	3.31%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	17.51%
Buyback Yield	-0.00%
Shareholder Yield	3.30%
Earnings Yield	18.90%
FCF Yield	-91.88%

Dividend Details

Stock Splits

The last stock split was on December 29, 2014. It was a forward split with a ratio of 1.01.

Last Split Date	Dec 29, 2014
Split Type	Forward
Split Ratio	1.01

Scores

Ahn-Gook Pharmaceutical has an Altman Z-Score of 2.23. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.23
Piotroski F-Score	n/a